Heart valve assemblies

Information

  • Patent Grant
  • 10595991
  • Patent Number
    10,595,991
  • Date Filed
    Thursday, May 30, 2019
    5 years ago
  • Date Issued
    Tuesday, March 24, 2020
    4 years ago
Abstract
A heart valve assembly comprises a first prosthesis configured to expand from an unexpanded state to an expanded state at which the first annular prosthesis contacts native tissue of a body lumen. The heart valve assembly also comprises a second prosthesis comprising a valve, and a connection adapter that secures the second prosthesis to the first prosthesis, the connection adapter having a multi-lobed circumference.
Description
BACKGROUND OF THE INVENTION
1. Field of the Invention

The present invention relates generally to a biologically implantable prosthesis, a heart valve assembly using the prosthesis, and methods of using the same within an annulus of the body.


2. Description of the Related Art

Prosthetic heart valves can replace defective human valves in patients. Prosthetic valves commonly include sewing rings or suture cuffs that are attached to and extend around the outer circumference of the prosthetic valve orifice.


In a typical prosthetic valve implantation procedure, the heart is incised and the defective valve is removed leaving a surrounding area of locally tougher tissue. Known heart valve replacement techniques include individually passing sutures through the tough tissue to form an array of sutures. Free ends of the sutures are extended out of the thoracic cavity and laid, spaced apart, on the patient's body. The free ends of the sutures are then individually threaded through an edge around the circumference of the sewing, ring. Once all sutures have been run through the ring, all the sutures are pulled up taught and the prosthetic valve is slid or “parachuted” down into place adjacent the tough tissue. Thereafter, the prosthetic valve is secured in place by traditional knot tying with the sutures.


The sewing ring is often made of a biocompatible fabric through which a needle and suture can pass. The prosthetic valves are typically sutured to a biological mass or annulus that is left when the surgeon removes the existing valve from the patient's heart. The sutures are tied snugly, thereby securing the sewing ring to the annulus and, in turn, the prosthetic valve to the heart.


Sewing rings can be tedious to secure to the valve orifice. Further, attaching the sewing ring, to the annulus can be time consuming and cumbersome. The complexity of suturing provides a greater opportunity for mistakes and requires a patient to be on cardiopulmonary bypass for a lengthy period. It is, also desirable to provide as large of a lumen through the prosthetic valve as possible to improve hemodynamics. However, techniques for attaching the sewing ring to the orifice typically require the area of the valve lumen be reduced to accommodate an attachment mechanism. For example, the sewing ring is typically retained on top of the annulus, resulting in a lumen that is, at the largest, the size of the original lumen.


A patient can also have a natural valve lumen that is detrimentally small. In these cases, the natural valve can be gusseted before the prosthetic valve is implanted. To gusset the natural valve, a longitudinal incision can be made along the wall of the lumen. The lumen can then be circumferentially expanded and the now-expanded incision can be covered with a patch graft or other membrane and stitched closed.


U.S. Pat. No. 4,743,253 to Magladry discloses a suture ring with a continuous compression ring. Magladry's ring is ductile, but provides a compressive, not expansive, force. In fact, the ring taught by Magladry is intended for placement over a heart valve and provides compression on the heart valve.


U.S. Pat. No. 6,217,610 to Carpentier et al. discloses an expandable annuloplasty ring. Carpentier et al. teach expanding the ring over the life of a patient by increasing the size of the ring by balloon dilatation. The ring is intended to remodel the shape of the valve annulus, not serve as a foundation to attach a second prosthesis and form a heart valve.


U.S. Pat. No. 5,984,959 to Robertson et al. discloses an expandable heart valve ring, for attaching a synthetic valve thereto and a tool for attaching the ring to the synthetic valve. Robertson et al. reach the ring as having tabs that are used to attach to the second prosthesis by using a second device to engage the tabs.


There is a need for a circumferentially expandable bio-prosthesis. There is also a need for a prosthesis and method that can expand an annulus and maintain an enlarged annulus circumference. Furthermore, there is a need for a minimally invasive heart valve replacement procedure. Also, there is a need for a prosthesis that can provide for the above and engagement with a second prosthesis, for example, the crown of a heart valve. Furthermore, there is a need for the above prosthesis that can self-engage a second prosthesis to improve implantation time.


BRIEF SUMMARY OF THE INVENTION

One embodiment of the disclosed prosthesis is a biologically implantable first prosthesis for a heart valve having a circumferentially expandable wall. The wall has a latitudinal cross-section perpendicular to the longitudinal axis, and a longitudinal cross-section parallel to the longitudinal axis. The prosthesis also has an engagement element configured to self-engage a second prosthesis.


The first prosthesis can also have a stop, where the stop prevents the wall from circumferentially decreasing. The first prosthesis can also have a fixturing device connector. The wall can also be corrugated. The wall can also have a turned lip, on its leading, edge. The first prosthesis can also be in an assembly where the first prosthesis can receive a second prosthesis, for example a crown.


Another embodiment of the prosthesis is a biologically implantable first prosthesis for a heart valve having a wall with a first edge and a second edge. The wall has a longitudinal axis at the center of the first prosthesis, and the first edge has an engagement element for engaging a second prosthesis. The engagement element is also turned toward the second edge.


The engagement element can be curved toward the second edge. The first edge can be the leading edge. The first prosthesis can also have a fixturing device connector that can be a port in the wall. The wall can also be corrugated. The first prosthesis can also be in an assembly with a second prosthesis connected to the engagement element. The second prosthesis can be a crown.


An embodiment of a method of implanting a heart valve in a valve annulus is attaching a first prosthesis to the valve annulus and attaching a second prosthesis to the first prosthesis. The first prosthesis has a circumferentially expandable wall. The wall has a longitudinal axis, and the wall has a latitudinal cross-section perpendicular to the longitudinal axis.


The first prosthesis can be a ring. The second prosthesis can be a crown. The wall of the first prosthesis can have a first terminal end and a second terminal end. Attaching the first prosthesis can include fixing the first prosthesis to a biological mass with a fixturing device. Attaching the first prosthesis can also include snap-fitting the second prosthesis to the first prosthesis.


Another embodiment of a method of implanting a heart valve in a valve annulus includes attaching a first prosthesis to, the valve annulus and attaching a second prosthesis to the first prosthesis. The first prosthesis has a wall having a first edge and a second edge. The wall also has a longitudinal axis. The first edge comprises an engagement element, and the engagement element is turned toward the second edge.


The engagement element can be turned away from the longitudinal axis. The first prosthesis can be a ring. The second prosthesis can be a crown. Attaching the crown can include snap-fitting the crown to the first prosthesis.


An embodiment of a method of increasing and maintaining the size of a biological valve annulus includes placing a circumferentially expandable first prosthesis in the annulus. The method also includes circumferentially expanding the first prosthesis, and circumferentially locking the first prosthesis.


Circumferentially expanding the first prosthesis can include increasing the radius of the annulus from about 0.1 mm (0.004 in.) to more than about 2.0 mm (0.08 in.). The first prosthesis can also have an engagement element configured to receive a second prosthesis.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a bottom view of an embodiment of the prosthesis.



FIG. 2 is a top perspective view of the embodiment of the prosthesis of FIG. 1.



FIG. 3 is a bottom view of another embodiment of the prosthesis.



FIG. 4 is a top perspective view of the embodiment of the prosthesis of FIG. 3.



FIG. 5 is a bottom view of another embodiment of the prosthesis.



FIG. 6 is a top perspective view of the embodiment of the prosthesis of FIG. 5.



FIG. 7 is a bottom view of another embodiment of the prosthesis with cut-away views of the collars.



FIG. 8 is a top perspective view of the embodiment of the prosthesis of FIG. 7 with cut-away views of the collars.



FIG. 9 is a bottom view of another embodiment of the prosthesis with cut-away views of the collars.



FIG. 10 is a top perspective view of the embodiment of the prosthesis of FIG. 8 with cut away views of the collars.



FIG. 11 is a top perspective view of another embodiment of the prosthesis with magnets.



FIG. 12 illustrates cross-section A-A of FIG. 11.



FIG. 13 is a top perspective view of another embodiment of the prosthesis with magnets.



FIG. 14 illustrates cross-section B-B of FIG. 13.



FIG. 15 is a top perspective view of another embodiment of the prosthesis with magnets.



FIGS. 16-18 are top views of various deformable embodiments of the prosthesis in unexpanded states.



FIG. 19 is a top view of the embodiment of the prosthesis of FIG. 12 in an expanded state.



FIGS. 20-22 illustrate various embodiments of the fixturing device connectors.



FIGS. 23-25 illustrate various embodiments of the receiving elements.



FIGS. 26 and 27 are cut-away views of various embodiments of the receiving elements.



FIGS. 28-33 illustrate various embodiments of the protrusions.



FIG. 34 illustrates the steering elements.



FIGS. 35-43 are cross-sections of various embodiments of the wall of the prosthesis.



FIG. 44 illustrates an embodiment of the prosthesis of FIG. 38.



FIGS. 45 and 46 illustrate cross-sections of the wall of the prosthesis with various embodiments of the covering.



FIGS. 47-52 illustrate various embodiments of the engagement element.



FIG. 53 is a cut-away view of an embodiment of positioning the prosthesis in an annulus with a solid view of the prosthesis.



FIG. 54 is a cut-away view of an embodiment of positioning the prosthesis in an annulus.



FIGS. 55 and 56 illustrate various embodiments of the protrusions and receiving elements when the prosthesis is not expanded.



FIG. 57 is a cut-away view of an embodiment of expanding the prosthesis.



FIGS. 58 and 59 illustrate an embodiment of an expansion tool.



FIGS. 60 and 61 illustrate another embodiment of an expansion tool.



FIGS. 62 and 63 illustrate various embodiments of the protrusions and receiving elements when the prosthesis is expanded.



FIG. 64 is a cut-away view of fixturing the prosthesis to a biological mass.



FIGS. 65-68 illustrate an embodiment of a method and assembly for fixturing the prosthesis to a biological mass.



FIG. 69 is a cut-away view of positioning the second prosthesis onto the first prosthesis with a solid view of the second, prosthesis.



FIG. 70 is a cut-away view of attaching the second prosthesis to the first prosthesis. FIGS. 71-77 are exploded views of various embodiments of attaching the second prosthesis to the first prosthesis.



FIG. 78 is an exploded view of an embodiment of attaching the second prosthesis to an adapter and attaching the adapter to the first prosthesis.



FIGS. 79 and 80 illustrate cross-sections C-C and D-D, respectively, from FIG. 78.



FIG. 81 is a top view of an embodiment of the first prosthesis with the second prosthesis attached thereto.



FIGS. 82-84 illustrate an embodiment of a method of removing the second prosthesis from the first prosthesis.





DETAILED DESCRIPTION


FIGS. 1 and 2 illustrate an embodiment of a biologically implantable first prosthesis 2. The first prosthesis 2 can have a wall 4. The wall 4 can have material strength and dimensions known to one having ordinary skill in the art to make the first prosthesis resiliently expandable. The wall 4 can have an open form or spiral longitudinal cross-section, as shown in FIG. 1. The longitudinal cross-section can be perpendicular to a central longitudinal axis 6.


The wall 4 can have a first terminal end 8 and a second terminal end 10. Each end 8 and 10 can be defined from a midpoint 12 of the wall 4 to a first terminus 14 or a second terminus 16 of the wall 4 at the respective end 8 or 10. The wall 4 can have an end difference length 18. The end difference length 18 can be the shortest angular length from the first terminus 14 to the second terminus 16. The wall 4 can also have a leading edge 20 and a trailing edge 22. The leading edge 20 and trailing edge 22 can be substantially perpendicular to the longitudinal axis 6. The first prosthesis 2 can have a circumference equivalent to a wall length 24 minus an end difference length 18. The wall 4 can have a wall height 25. The wall height can be from about 3.18 mm (0.125 in.) to about 12.7 mm (0.500 in.), for example about 8.26 mm (0.325 in.). The wall 4 can also be void of any attachment device with which to fix one end 8 or 10 of the wall 4 to the other end 8 or 10 of the wall 4. The wall 4 can made from stainless steel alloys, nickel titanium alloys (e.g., Nitinol), cobalt-chrome alloys (e.g., ELGILOY® from Elgin Specialty Metals, Elgin, Ill.; CONICHROME® from Carpenter Metals Corp., Wyomissing, Pa.), polymers such as polyester (e.g., DACRON® from E. I. Du Pont de Nemours and Company, Wilmington, Del.), polypropylene, polytetrafluoroethylene (PTFE), expanded PTFE (ePTFE), polyether ether ketone (PEEK), nylon, extruded collagen, silicone, radiopaque materials or combinations thereof. Examples of radiopaque materials are barium, sulfate, titanium, stainless steel, nickel-titanium alloys and gold.



FIGS. 3 and 4 illustrate an embodiment of the first, prosthesis 2 that can be mechanically expandable. A first protrusion 26 and a second protrusion 28 at the first terminal end 8 can extend from the wall 4. The protrusions 26 and 28 can extend perpendicular to the wall 4 or perpendicular to the longitudinal axis 6. The protrusions 26 and 28 can be tabs, brads, extensions, balls, rods or a combination thereof. The protrusions can have a protrusion depth 30 sufficient to retain the wall 4.


The wall 4 can also have a first receiving element 32 and a second receiving element 34 at the second terminal end 10 that receive or engage the first protrusion 26 and the second protrusion 28, respectively. The wall 4 can also have more or less (e.g., one or zero) receiving elements 32 or 34. The receiving elements 32 and 34 can be holes in the wall 4. The receiving elements 32 and 34 can also be divets, dimples, hooks, slots, or a combination thereof. The protrusions 26 and 28 and receiving elements 32 and 34 can act together as a stop, or an interference fit, to prevent the first prosthesis 2 from circumferentially extending or decreasing beyond desired limits.



FIGS. 5 and 6 illustrate an embodiment of the first prosthesis 2 that can have protrusions 26 and receiving elements 32 that can be dimples. The protrusions 26 and receiving elements 32 can be in a first row 36, a second row 38, and additional rows 40. The protrusions 26 can also be in a first column 42, a second column 44, and additional columns 46. The receiving elements 32 can have a receiving element depth 46 within the same range of sizes as the protrusion depth 36, above.



FIGS. 7 and 8 illustrate an embodiment of the first prosthesis 2 that can have the protrusions 26 and 28 extending from the first terminus 14 substantially at a tangent to the wall 4. The protrusions 26 and 28 can be rods 48 with balls 50 at the ends of the rods 48. The receiving elements 32 and 34 can extend from the second terminus 16 substantially at a tangent to the wall 4. The receiving elements 32 and 34 can be collars 52 for receiving the balls 50. The wall 4 can have a longitudinal cross-section in the shape of a circular open curve, as shown in FIG. 7. A circumferential gap 54 can exist between the first terminus 14 and the second terminus 16.



FIGS. 9 and 10 illustrate an embodiment of the first prosthesis 2 that can have different embodiments of protrusions 26 and 28 and receiving elements 32 and 34. The first prosthesis 2 of FIGS. 9 and 10 can also have a wall angle 56 relative to the longitudinal axis 6 controlled by the dimensions of the protrusions 26 and 28 and receiving elements 32 and 34 and the locations of the protrusions 26 and 28 and receiving elements 32 and 34 on the wall 4. The wall angle 56 can be from about 10° to about 60°, more narrowly from about 20° to about 45°, for example about 25°. The protrusions 26 and 28 and the receiving elements 32 and 34 can be located along the trailing edge 22, the leading edge 20 or therebetween.



FIGS. 11 and 12 illustrate an embodiment of the first prosthesis 2 with the wall 4 having a bottom segment 58 and a top segment 60. The first prosthesis 2 can be deformably circumferentially expandable. The bottom segment 58 can have the wall angle 56 relative to the longitudinal axis 6. The angle between the bottom segment 58 and the top segment 60 can be a joint angle 62. The joint angle 62 can be from about 90° to about 180°, more narrowly from about 90° to about 160°, for example about 120°.


The wall 4 can also have a first steering groove 64 that can extend over the length of the bottom segment 58. The wall 4 can also have a second steering, groove 66 that can extend over a portion of the length of the bottom segment 58. The grooves 64 and 66 can help angularly align, with respect to, the longitudinal axis 6, a second prosthesis 68 that can be attached to the first prosthesis 2. The grooves 64 and 66 can also prevent the rotation of the first prosthesis 2 with respect to the second prosthesis 68. The second groove 66 can also help to longitudinally align the second prosthesis 68.


The first prosthesis 2 can also have engagement elements, for example top magnets 70 in the top segment 60 and bottom magnets 72 in the bottom segment 58. The magnets 70 and 72 can have a magnet height 74, a magnet width 76 and a magnet length 78. The magnets 70 and 72 can be rare earth, high strength-type magnets. The magnets can be made from neodymium-iron-boron and can be encapsulated in a coating made from PTFE (e.g., TEFLON® (from E. I. Du Pont de Nemours and Company, Wilmington, Del.), PEEK, a similarly inert and stable biocompatible polymer, or a combination thereof. A radiopaque material can also be added to the coating. The top and/or, bottom magnets 70 and/or 72 can be customized to allow for only one angular orientation of the second prosthesis 68 by changing the polarity of one or an irregular number of magnets 70 and/or 72 (e.g., positive) to be different from the polarity of the remaining magnets 70 and/or 72 (e.g., negative).


In one example, 24 magnets 70 can be evenly distributed around the circumference of the first prosthesis 2. The magnet heights 74 can be about 3.175 mm (0.125 in.). The magnet widths 76 can be about 3.175 mm (0.125 in.). The magnet lengths 78 can be about 1.59 mm (0.0625 in.).



FIGS. 13 and 14 illustrate an embodiment of the first prosthesis 2 similar to the embodiment illustrated in FIGS. 11 and 12. The present embodiment of the first prosthesis 2 can have a cloth sewing surface 80. The magnets 70 can be square or rectangular in cross-section (as shown in FIGS. 11 and 12) or oval or circular in cross-section (as shown in FIGS. 13 and 14). The wall 4 can also be multiple segments 58 and 60, as shown in FIGS. 11 and 12, or a single segment, as shown in FIGS. 13 and 14.



FIG. 15 illustrates an embodiment of the first prosthesis 2 similar to the embodiment illustrates in FIGS. 11 and 12. The first prosthesis 2 in the present embodiment can also be mechanically and/or resiliently circumferentially expandable.



FIGS. 16-18 illustrates deformable embodiments of the first prosthesis 2. In an unexpanded state, the first prosthesis 2 can have an unexpanded diameter 82. The embodiment of the first prosthesis 2 in FIG. 16 can have a smooth wall 4, thereby relying on hoop strain to expand. In FIG. 17, the embodiment can have an accordioned wall 4 with multiple pleats or folds 84. The folds 84 can open or unfold to maximize circumferential expansion of the wall 4 during use. The embodiment of the first prosthesis 2 in FIG. 18 can have a single large fold 84 for the same purpose as the folds 84 shown in FIG. 17, FIG. 1.9 illustrates a deformable embodiment of the first prosthesis 2 in an expanded state. A radial force, as shown by arrows, directed away from the longitudinal axis 6 can expand the first prosthesis 2 to an expanded diameter 86. Materials and dimensions of the first prosthesis 2 can be selected by one having ordinary skill in the art to permit the ratio of the unexpanded diameter 82 to the expanded diameter 86 to be from about 0% to about 50%, more narrowly from about 5% to about 20%, yet more narrowly from about 9% to about 12%, for example about 9.5%.



FIG. 20 illustrates a length of the wall 4 that can have a first fixturing device connector 88 and a second fixturing device connector 90. The fixturing device connectors 88 and 90 can be ports or holes in the wall 4. The fixturing device connectors 88 and 90 can be ovular and can have a fixturing device connector height 92 and a fixturing device connector length 94. The fixturing device connector height 92 can be from about 0.51 mm (0.020 in.) to about 3.18 mm (0.125 in.), more narrowly from about 1.0 mm (0.040 in.) to about 1.5 mm (0.060 in.), for example about 1.3 mm (0.050 in).



FIG. 21 illustrates a length of the wall 4 that can have first, second, and additional fixturing device connectors 88, 90 and 96. The fixturing device connectors 88, 90 and 96 can be circular in shape. FIG. 22 illustrates a length of the wall 4 that can have the fixturing device connectors 88, 90 and 96 attached to the leading and trailing edges 20 and 22. The fixturing device connectors 88, 90 and 96 can be made from fabric or metal, for example polymers such as polyester (e.g., DACRON® from E. I. Du Pont de Nemours and Company, Wilmington, Del.), polypropylene, PTFE, ePTFE, nylon, extruded collagen, silicone, stainless steel alloys, nickel-titanium alloys (e.g., Nitinol), cobalt-chrome alloys (e.g., ELGILOY® from Elgin Specialty Metals, Elgin, Ill., CONICHROME® from Carpenter Metals Corp., Wyomissing, Pa.) or combinations thereof. Variously shaped and configured fixturing device connectors 88, 90 and 96 can be on the same wall 4.



FIG. 23 illustrates a length of the wall 4 that can have the receiving elements 32 and 34. The receiving elements 32 and 34 can be ports or holes in the wall 4. The receiving elements 32 and 34 and the fixturing device connectors 88, 90 and 96 can be the same element. The receiving elements 32 and 34 can have a first setting position 98 and a first neck 100 at one end of the first setting position 98. The first setting position 98 can have a setting position length 102 from about 4 mm (0.2 in.) to about 10 mm (0.4 in.), for example about 6.3 mm (0.25 in.). The first neck 100 can have a neck width 104. The first neck 100 can be at a first end of a second setting position 106. The receiving elements 32 and 34 can have more or less than two setting, positions 98 and 106 (e.g., one or zero). At a second end of the second setting position 106, the second setting position 106 can have a second neck 108. The second neck 108 can be at a first end of a final stop position 110. The final stop position 110 can have a final stop length 112.


The first and second setting positions 98 and 106 can lead to the first and second necks 100 and 108, respectively, with a ramp angle 114. The stop position 110 and the second setting position 106 can lead to the second 108 and first necks 100, respectively, with a stop angle 116.



FIG. 24 illustrates narrowing, oval or teardrop-shaped receiving elements 32 and 34. FIG. 25 illustrates rectangular receiving elements 32 and 34.



FIG. 26 illustrates the receiving element 32 that can be in the shape, of a collar or sleeve. The receiving element 32 can be attached by a connection zone 118 to a rod (not shown) extending from the wall 4 or to the wall 4 itself. The receiving element 32 can have first wedges 120 and second wedges 122. The length between the closest point of the first wedges 120 or of the second wedges 122 can be the neck width 104. The wedges 120 and 122 can revolve around the entire receiving element 32, thereby forming a single, circular first wedge 120 and a single, circular second wedge 122 (when seen in three-dimensions).


A receiving element shaftway 124 can be open at one end of the receiving element 32. The receiving element 32 can have a first narrowing 126 near the connection zone 118 and a second narrowing 128 near the receiving element shaftway 124. FIG. 27 illustrates the receiving element 32 that can have the wedges 120 and 122 shaped as scales or stop tabs.


A length of the wall 4 that can have protrusions 26 and 28 is illustrated in FIG. 28. The protrusions 26 and 28, shown alone in various embodiments in FIGS. 29 and 25, can be made from an extension 130 and a cuff 132. The extension 130 can be shaped cylindrically or, as shown in FIG. 30, as a shaft with a triangular cross-section. The extension 130 can have an extension height 134 and an extension width 136. The extension height 134 can be from about 0.51 mm (0.020 in.) to about 2.54 mm (0.100 in.), for example about 1.3 mm (0.050 in.). The final stop length 112 can be from about the extension width 136 to about 10 mm (0.4 in.), for example about 6.3 mm (0.25 in.).


The cuff 132 can be shaped as a circle or a square and can be substantially flat in depth. The cuff 132 can, have a cuff height 138 and a cuff width 140. The cuff height 138 can be from about the fixturing device connector height 92 to about 5.08 mm (0.200 in.), for example about 2.0 mm (0.080 in). The cuff width 140 can be within the range for the cuff height 138, above.



FIG. 31 illustrates a length of the wall 4 having the protrusions 26 and 28 formed from tabs cut out of the wall 4. Cut holes 142 can exist in the wall 4 where the material in the protrusions 26 and 28 was located in the wall 4 before being cut out.



FIG. 32 illustrates a length of the wall 4 that can have a first set and a second set of protrusions 26 and 28 extending from the wall 4. The wall 4 can have a wall radius of curvature 144. The protrusions 26 and 28 can have protrusion radii of curvature 146.


The protrusion radii of curvature 146 can be from about the wall radius of curvature 144 to infinity.



FIG. 33 illustrates a length of the wall 4 that can have an engagement element 148. The engagement element 148 can be shaped as a lip and wrapped around the protrusion 26. The engagement element 148 can enable the first prosthesis 2 to self-engage the second prosthesis 68. For example, the engagement element 148 can snap-fit to the second prosthesis 68.



FIG. 34 illustrates the first terminal end 8 and the second terminal end 10. The second terminal end 10 can have a first guide 150 and a second guide 152 that can wrap around the leading edge 20 and the trailing edge 22, respectively, of the first terminal end 8. The first terminal end 8 can slide angularly, with respect to the longitudinal axis 6, within the guides 150 and 152. The guides 150 and 152 can also minimize the risk of the first terminal end 8 moving too far away from or becoming misaligned from the second terminal end 10.



FIGS. 35-43 illustrate embodiments of the first prosthesis 2 at a latitudinal cross-section. The latitudinal cross-section can be a cross-section parallel with the longitudinal axis 6. FIG. 35 illustrates an embodiment with the wall 4 having a corrugated latitudinal cross-section. FIG. 36 illustrates an embodiment with the wall 4 having a straight latitudinal cross-section, parallel with the longitudinal axis 6.



FIG. 37 illustrates an embodiment having the trailing edge 22 angled toward the longitudinal axis 6 at the wall angle 56. FIG. 38 illustrates an embodiment having the trailing edge 22 angled away from the longitudinal axis 6 at the wall angle 56.



FIG. 39 illustrates an embodiment having a wall 4 convex toward the longitudinal axis 6. The wall 4 can be straight or have a lateral convex radius of curvature 154. FIG. 40 illustrates an embodiment having a wall 4 concave toward the longitudinal axis 6. The wall 4 can have a lateral concave radius of curvature 156 within the same range as the lateral convex radius of curvature 154.



FIG. 41 illustrates an embodiment having a wall 4 with a top segment 60, a middle segment 158 and a bottom segment 58. The top segment 60 and leading edge 20 can be angled away from the longitudinal axis 6. The bottom segment 58 and trailing edge 22 can be angled away from the longitudinal axis 6. The middle segment 158 can remain parallel to the longitudinal axis 6.



FIG. 42 illustrates an embodiment having the top segment 60 and the leading edge 20 that can be angled toward the longitudinal axis 6. The bottom segment 58 and trailing edge 22 can also be angled toward the longitudinal axis 6. The middle segment 158 can remain parallel to the longitudinal axis 6.



FIGS. 43 and 44 illustrate an embodiment of the wall 4 that can have a bottom segment 58 that can extend from the wall 4 at a retainer angle 160 with respect to the longitudinal axis 6 from about 0° to about 90°, more narrowly from about 10° to about 50°, for example about 30°. The bottom segment 58 can also have cuts 162, shown in FIG. 44. The cuts 162 can minimize stresses when the bottom segment 58 fans away from the middle segment 158. The bottom segment 58 can also act as a retention element, extending beyond the typical trailing edge 22 and stabilizing the first prosthesis 2 after the first prosthesis 2 is implanted.



FIG. 45 illustrates a cross-section of the wall 4 that can have a fabric covering 164, for example polyester (e.g., DACRON® from E. I. du Pont de Nemours and Company, Wilmington, Del.), polypropylene, PTFE, ePTFE, nylon, extruded collagen, silicone or combinations thereof. The fabric can be attached to the wall 4 at a first attachment point 166 and a second attachment point 168. The bare area of the wall between the attachment points 166 and 168 can be the engagement surface 170. The second prosthesis 68 can engage the first prosthesis 2 at the engagement surface 170.



FIG. 46 illustrates a cross-section of the wall 4 covered entirely by the covering 164. The second prosthesis 68 can also engage the first prosthesis 2 at the engagement surface 170 covered by the covering 164.



FIG. 47 illustrates a length of wall 4 with the engagement element 148, shaped as an open lip, on the leading edge 20. The engagement element 148 can be turned toward the longitudinal axis 6 and toward the trailing edge 22. FIG. 48 illustrates the engagement element 148 turned away from the longitudinal axis 6 and toward the trailing edge 22.



FIGS. 49 and 50 illustrate an embodiment of the first prosthesis 2 that can have a first length 172, a second length 174 and a third length 176. The lengths 172, 174 and 176 can be separated by cuts 162 in the wall 4. The engagement element 148 on the first length 172 and third length 176 can turn toward the longitudinal axis 6. The top and middle segments 60 and 158 of the first length 172 and the third length 176 can be bent away from the bottom segment 58 as shown by the arrows in FIG. 50. The top and middle segments 60 and 158 of the second length 174 can be similarly bent but in the opposite direction to the top and middle segments 60 and 158 of the first and third lengths 172 and 176. The engagement element 148 on the second length 174 can turn away from the longitudinal axis 6. A lip length 178 can be the length between, a first lip edge 180 of the engagement element 148 on the first length 172 or third length 176 and a second lip edge 182 of the engagement element 148 on the second length 174. The lip length 178 can be small enough to form a seam, crease or seat 184 to aid in seating, receiving and engaging a second prosthesis.



FIG. 51 illustrates a length of the wall 4 that can have the lengths 172, 174 and 176. The engagement elements 148 on the first length 172 and third length 176 can turn away from the longitudinal axis 6. The engagement element 148 on the second length 174 can turn toward the longitudinal axis 6. The engagement element 148 can then engage a second prosthesis on both sides of the wall 4.



FIG. 52 illustrates an embodiment that can have springs 186. One segment of each spring 186 can be a latch 188. The springs 186 can have windings 190 around a rail 192 fixed under the engagement element 148. The springs 186 can also have retaining legs 194 pressed against the wall 4. The latches 188 can be biased to contract, as shown by arrows 196, against the wall 4. The latches 188 can be held in the uncontracted position shown in FIG. 52 by interference beams 198. The interference beams 198 can be directly or indirectly rigidly attached to each other at a proximal end (in the direction, of arrows 200) to minimize the interference beams 198 from deflecting under the force, shown by arrows 196, from the latches 188. The interference beams 198 can be removed, as shown by arrows 200, allowing the latches 188 to contract, as shown by arrows 196, against, for example, the second prosthesis, once the second prosthesis is positioned within the reach of the latches 188.


Method of Making

The wall 4 can be made from methods known to one having, ordinary skill in the art. For example, the wall 4 can be molded or machined. The engagement element 148, the corrugation and any other bends in the wall 4 can be formed (e.g., pressure formed), molded or machined into the wall 4 or bent into the metal with methods known to one having ordinary skill in the art.


The protrusions 26 and 28 and the receiving elements 32 and 34 (e.g., at the connection zone 118) can be fixed to the to the wall 4 or formed of the wall 4 by crimping, stamping, melting, screwing, gluing, welding, die cutting, laser cutting, electrical discharge machining (EDM) or a combination thereof. Cuts 162 and holes in the wall 4 can be made by die cutting, lasers or EDM.


Any part of the first prosthesis 2, or the first prosthesis 2 as a whole after assembly, can be coated by dip-coating or spray-coating methods known to one having ordinary skill in the art. One example of a method used to coat a medical device for vascular use is provided in U.S. Pat. No. 6,358,556 by Ding et al. and hereby incorporated by reference in its entirety. Time release coating methods known to one having ordinary skill in the art can also be used to delay the release of an agent in the coating. The coatings can be thrombogenic or anti-thrombogenic. For example, coatings on the inside of the first prosthesis 2, the side facing the longitudinal axis 6, can be anti-thrombogenic, and coatings on the outside of the first prosthesis, the side facing away from the longitudinal axis 6, can be thrombogenic.


The first prosthesis 2 can be covered with a fabric, for example polyester (e.g., DACRON® from E. I. du Pont de Nemours and Company, Wilmington, Del.), polypropylene, PTFE, ePTFE, nylon, extruded collagen, silicone or combinations thereof. Methods of covering an implantable device with fabric are known to those having ordinary skill in the art.


Method of Use

The first prosthesis 2 can be introduced in an unexpanded state to an antechamber 202 adjacent to a targeted valve annulus 204 by methods known to one having ordinary skill in the art. FIG. 53 illustrates positioning and lowering, as shown by the arrows, the first prosthesis 2 to the annulus 204. Because of the collapsible and expandable nature of the first prosthesis 2, the procedure of implanting the first prosthesis 2 can be accomplished thorascopically, endoscopically and/or endoluminally. The first prosthesis 2 can be placed accurately enough into the annulus 204 so that the first prosthesis 2 does not block vessel openings in chambers neighboring the annulus 204 (e.g., the openings for the coronary vessels) and does not fall out of the annulus 204 (e.g., into a chamber of the heart, a ventricle for example). The annulus 204 can have an initial annulus diameter 206. FIG. 54 illustrates positioning and seating the first prosthesis 2.


When the first prosthesis 2 is completely unexpanded, the protrusion 26 and the receiving element 32 can be aligned as illustrated in FIGS. 55 and 56. As shown in FIG. 55, the extension 130 can be located in the first setting position 98. As shown in FIG. 56, the ball 50 can be located in the first setting position 98.


The first prosthesis 2 can be circumferentially expanded, as illustrated by the arrows in FIG. 57. The prosthesis can have an expanded annulus diameter 208. The expanded annulus diameter 208 can, be from about 5 mm (0.2 in.) to about 40 mm (1.6 in.), depends on, the size of the initial annulus diameter 206, and can be influenced, by other anatomy, anomalies (e.g., narrowing, stenosis) and, age (e.g., pediatric sizing). An expansion tool 210 can be used to expand the first prosthesis 2. Examples of the expansion tool 210 include a balloon, back sides of a clamp jaws, or a flexible plug assembly as shown in FIGS. 58-61. Another example of the expansion tool 210 is disclosed in U.S. Pat. No. 5,984,959 to Robertson et al. which is herein incorporated by reference in its entirety.



FIG. 58 illustrates a flexible plug 212 that can be cylindrical and have a static plate 214 on a first side 216. The plug 212 can be made from polymers, for example polyurethane or silicone. The plug 212 can have a hole 218 in the center of the plug 212. A rigid inner tube 220 can pass through the hole 218 and be tied into a knot or pull against a washer 222 on the first side 216. A squeeze plate 224 can be fixedly attached to an end of a rigid outer tube 226. The outer tube 226 can be larger than the inner tube 220, and the inner tube 220 can slide through the outer tube 226. A force in the direction of the plug 212 can be applied to the outer tube 226, as shown by arrows 228. A force in the direction away from the plug 212 can be applied to the inner tube 220, as shown by arrows 230. The plug can have a resting diameter 232 when no forces are applied.


Once the forces shown by the arrows 228 and 230 are applied to the plug 212, the plug 212 can deform away from the tubes 220 and 226, as shown by arrows 234 and illustrated in FIG. 59. Once deformed, the plug 212 can have an expanded diameter 236. The resting diameter 232 and the expanded diameter 236 can be sized appropriately to the dimensions of the first prosthesis 2. The deformation of the plug 212 can also create forces in the same direction as the arrows 234. When the forces shown by the arrows 228 and 230 are removed, the plug 212 can return to the shape shown in FIG. 58.



FIG. 60 illustrates another embodiment of the plug 212. The plug 212 can have a recessed top surface 238 and a recessed bottom surface 240. A top perimeter 242 and a bottom perimeter 244 can be angled from the recessed surfaces 238 and 240 to meet a wall 246 of the plug 212. The squeeze plate 224 and the static plate 214 can both be conically or partially conically shaped to fit the perimeters 242 and 244 of the plug 212. As shown in FIG. 61, when the forces shown by the arrows 228 and 230 are applied, the plug wall 246 can expand radially and maintain a flat surface.


When the first prosthesis 2 is completely expanded, the protrusion 26 and the receiving element 32 can be aligned as illustrated in FIGS. 62 and 63. As shown in FIG. 62, the extension 130 can be located in the final stop position 110. As shown in FIG. 63, the ball 50 can be located in the final stop position 110. The interference fit caused by the stop angle 116 and neck width 104 of the second neck 108 can prevent the protrusion 26 from re-entering, the second setting position 106. In addition, when expanded the first prosthesis frictionally engages the annulus, expanding the annulus diameter. When expanded, the first prosthesis 2 can also trap vascular plaque between the wall 4 and the perimeter of the annulus 204. The first prosthesis 2 can also be partially expanded, forcing the protrusion 26 into the second setting position 106.


Fixturing devices 248 can be used to fix the first prosthesis 2 through the fixturing device connectors 88 to the biological mass of the annulus 204, as shown in FIG. 64. Examples of fixturing devices 88 are sutures, clips, staples, pins and combinations thereof.



FIGS. 65-68 illustrate one embodiment of a method of fixing the first prosthesis 2 to the annulus 204. FIG. 65 illustrates an embodiment of a fixturing device assembly 250. The fixturing device assembly 250 can have a needle 252. The needle 252 can be curved or have a curved tip. The needle 252 can also be attached at a proximal end to a distal end of a line 254. The proximal end of the needle 252 can also be attached directly to the can 256 without the line 254 or formed as the can 256. A proximal end of the line 254 can be attached to a can 256. The can 256 can be a flexible cylindrical storage device, for example a coil. The can 256 can removably hold the fixturing device 248. The fixturing device 248 can have a fixturing element 258, for example, a wire or fiber. The fixturing element 258 can, have a ball 260 at a first end and a radially expandable portion 262 at a second end. The fixturing device 248 can also have a pledget 264 on the fixturing element 258 between the ball 260 and the expandable portion 262.


The fixturing device assembly 250 can be positioned so the needle 252 is adjacent to the fixturing device connector 88, as shown by arrows 266. The needle 252 can then be pushed through the fixturing device connector 88 and the annulus 204, as shown by arrow 268 in FIG. 66. The needle 252 can then be pulled away from the annulus 204, as shown by arrow 270 in FIG. 67. The can 256 can follow the path of the needle 252 through the annulus 204, as shown by arrow 272. The pledget 264 can also be larger than the fixturing device connector 88, and the pledget 264 can provide an interference fit against the fixturing device connector 88. The needle 252 can continue to be pulled away from the annulus 204, pulling the can 256 out of the annulus 204, as shown by arrow 274 in FIG. 68. The interference fit of the pledget 264 against the fixturing device connector 88 can provide a resistive force holding the fixturing device 248 and causing the fixturing element 258 to slide out of the can 256 as the needle 252 is pulled away from the annulus 204. The radially expandable portion 262 can then radially expand, thereby causing the first prosthesis 2 and the annulus 204 to be fixed between the pledget 264 and the radially expandable portion 262.


The inner surface of the can 256 can be designed—for example, by coiling, corrugation, or other roughening—to adjust the friction between the inner surface of the can 256 and the fixturing device 248. This friction can influence the amount of resistive force necessary to remove the fixturing device 248 from the can 256. The resistive force can be larger than about the force necessary to have the fixturing device 248 fall out of the can 256 before the fixturing device 248 has passed through the annulus 104. The resistive force can also be less than about the force necessary to deform the pledget 264 sufficient to pull the pledget 264 through the fixturing device connector 88. The resistive force can be, for example, about 1.1 N (0.25 lbs.).


A second prosthesis 68 can then be positioned on the engagement element 148, as shown by the arrows in FIG. 69. Once seated on the engagement element 148, the second prosthesis 68 can then be engaged by the first prosthesis 2, as shown in FIG. 70. Examples of second prostheses 68 include a connection adapter and a heart valve crown with leaflets 276, for example, U.S. Pat. No. 6,371,983 to Lane which is herein incorporated by reference in its entirety.



FIG. 71 illustrates another embodiment of the heart valve assembly 278 with the second prosthesis 68. The first prosthesis 2 can have a tapered wall 280 to provide a longitudinal stop and to guide insertion of the second prosthesis 68 into the first prosthesis 2, as shown by arrows 282. The tapered wall 280 can also push back the annulus 204, maintaining the expanded annulus diameter 208 when the second prosthesis 68 is engaged in the first prosthesis 2. The second prosthesis 68 can have spring lock tabs 284 to fix to the engagement element 148. The spring lock tabs 284 can angle outwardly from the longitudinal axis 6. The first and second prostheses 2 and 68 can have first and second prosthesis diameters 288 and 290, respectively. The first prosthesis diameter 288 can be larger than the second prosthesis diameter 290. FIG. 72 illustrates the embodiment of the heart valve assembly 278 of FIG. 71, however the second prosthesis diameter 290 can be larger than the first prosthesis diameter 288, and the spring lock tabs 284 can angle inwardly toward the longitudinal axis 6. The first prosthesis 2 and the second prosthesis 68 act to maintain the expanded annular lumen diameter 208.



FIG. 73 illustrates another embodiment of the heart valve assembly 278 with a second prosthesis 68 that can have fixation points 286 that align with fixation points 286 on the first prosthesis 2 to allow insertion of sutures, grommets, clips 292 or pins 294 through the aligned fixation points 286 to fix the first prosthesis 2 to the second prosthesis 68.



FIG. 74 illustrates another embodiment of the heart valve assembly 278 with a multi-lobed stiffening ring 296 that can be placed near the edge of the second prosthesis 68 as shown by arrows 298. The second prosthesis 68 can have several flaps 300. The flaps 300 can wrap around the stiffening ring 296, as shown by arrows 302. The wrapped stiffening ring 296 can increase the rigidity of the second prosthesis 68 and can engage, the engagement element 148.



FIG. 75 illustrates yet another embodiment of the heart valve assembly 278 with an embodiment of the first prosthesis 2 equivalent to the embodiment in FIG. 52. The second prosthesis 68 can have latch openings 304 to receive the latches 188. When the second prosthesis 68 is lowered into the first prosthesis 2, the interference beams 198 can be removed, as shown by arrows 200. The latches 188 can then contract onto the latch openings 304.



FIG. 76 illustrates an embodiment of the heart valve assembly 278 with an embodiment of the first prosthesis 2 equivalent to the embodiment in FIGS. 11 and 12. The second prosthesis can have a rib 306 to fit within the groove 64. The second prosthesis 68 can also have an upper arm 308 that can have a top magnet 70 and a lower arm 310 that can have a bottom magnet 72. The magnets 70 and 72 in the second prosthesis 68 can have polarities opposite of the polarities of the corresponding magnets 70 and 72 in the first prosthesis 2. FIG. 77 illustrates an embodiment of the heart valve assembly 278 with an embodiment of the first prosthesis equivalent to the embodiment in FIGS. 13 and 14.



FIG. 78 illustrates an embodiment of the heart valve assembly 278 with an adapter 312 connecting the second prosthesis 68 to the first prosthesis 2. The adapter 312 can have spring lock tabs 284 to fix to the engagement element 148, and the adapter 312 can have a stop ridge 314 to position the adapter 312 against the wall 4.


The adapter 312 can also have fixation points 286 that align with other fixation points 286 on the second prosthesis 68 to allow insertion of sutures, grommets, clips, pins, or the fixturing devices 248, through the aligned fixation points 286 to fix the adapter 312 to the second prosthesis 68. The second prosthesis 68 can also be lowered into the top of the adapter 312 as shown by arrow 316. The adapter 312 can attach to the inside or outside of the first or second prosthesis 2 or 68 depending on the dimensions and the orientation of the attachment apparatus (e.g., unidirectional clips).


The adapter 312 can also have multiple shapes of cross-sections, as shown in FIGS. 79 and 80. As shown in FIG. 79, cross-section C-C can have three lobes 318 and three scallops 320. One scallop 320 can be between each lobe 318. Cross-section C-C can be the same as the cross-section of the second prosthesis 68 where the second prosthesis 68 engages the adapter 312. As shown in FIG. 80, cross-section D-D can be circular. Cross-section D-D can be the same as the cross-section of the first prosthesis 2 where the first prosthesis 2 engages the adapter 312.



FIG. 81 illustrates a second prosthesis 68 received by a first prosthesis 2. The second prosthesis 68 can have three lobes 318. The second prosthesis can have a scallop 320 between each two lobes 318. The scallop gap 322 between each scallop 320 and the wall 4 can be covered by a fabric during use of the prostheses 2 and 68.



FIG. 82 illustrates that a lever device 324, for example a clamp or scissors, can be forced, as shown by arrows, into the scallop gap 322. As illustrated in FIG. 83, once legs 326 of the lever device 324 are placed next to two scallops 320, the lever device 324 can be squeezed, as shown by arrows, thereby crushing the second prosthesis 68 and separating it from the first prosthesis 2. As illustrated in FIG. 84, the second prosthesis 68 can be removed from the first prosthesis 2, as shown by arrows, once the second prosthesis 68 is separated from the first prosthesis 2. Once the second prosthesis 68 is removed, a new second prosthesis 68 can be added as described above. Leaflet failure can be fixed easily and inexpensively by implanting a new second prosthesis 68. Circumferential expansion of the first prosthesis 2 and replacement of the second prosthesis 68 to account for pediatric expansion of the valve can also be performed easily and inexpensively.


It is apparent to one skilled in the art that various changes and modifications can be made to this disclosure, and equivalents employed, without departing from the spirit and scope of the invention. Elements shown with any embodiment are exemplary for the specific embodiment and can be used on other embodiments within this disclosure.

Claims
  • 1. A prosthetic valve assembly comprising: a first annular prosthesis having a frame configured to have a first diameter in a collapsed state for introduction into a body lumen and a second diameter in an expanded state for implantation within an annulus of a heart, the first annular prosthesis having a first alignment element, wherein the first alignment element is a groove that extends in parallel with a longitudinal axis of the first annular prosthesis; anda second annular prosthesis including a prosthetic valve, the second annular prosthesis having a second alignment element that is configured to align with the first alignment element when the second annular prosthesis is positioned within the first annular prosthesis in the expanded state.
  • 2. The prosthetic valve assembly of claim 1, wherein the second alignment element is a rib that protrudes outwardly from the second annular prothesis, the rib being configured to slide within the groove of the first annular prosthesis when the first annular prosthesis and the second annular prosthesis are mated with each other in vivo.
  • 3. The prosthetic valve assembly of claim 2, wherein when the second annular prosthesis is positioned within the first annular prosthesis the first and second alignment elements prevent rotation of the first annular prosthesis relative to the second annular prosthesis.
  • 4. The prosthetic valve assembly of claim 1, wherein during positioning of the second annular prosthesis within the first annular prosthesis the first alignment element of the first annular prosthesis aids in angularly aligning the second annular prosthesis with respect to a longitudinal axis of the first annular prosthesis.
  • 5. The prosthetic valve assembly of claim 1, wherein the frame of the first annular prosthesis has a first wall segment angled outwardly from a second wall segment thereof.
  • 6. The prosthetic valve assembly of claim 5, wherein the first alignment element is disposed on the second wall segment.
  • 7. The prosthetic valve assembly of claim 1, wherein the first annular prosthesis includes a first engagement element and the second annular prosthesis includes a second engagement element, the first engagement element and the second engagement element being configured to engage each other to attach the first and second annular prostheses together in vivo.
  • 8. The prosthetic valve assembly of claim 7, wherein the first and second engagement elements provide a snap-fit connection between the first and second annular prostheses.
  • 9. The prosthetic valve assembly of claim 7, wherein the first and second engagement elements provide a magnetic connection between the first and second annular prostheses.
  • 10. The prosthetic valve assembly of claim 7, wherein the first and second alignment elements are configured to longitudinally align the second annular prosthesis with the first annular prosthesis as the second annular prosthesis is inserted into engagement with the first annular prosthesis in a predetermined angular orientation.
  • 11. The prosthetic valve assembly of claim 1, wherein the frame of the first annular prosthesis is resiliently circumferentially expandable.
  • 12. The prosthetic valve assembly of claim 1, wherein the frame of the first annular prosthesis is mechanically circumferentially expandable.
  • 13. A prosthetic valve assembly comprising: a first annular prosthesis configured to be implantable into an annulus within a heart, the first annular prosthesis including a frame that is circumferentially expandable from a first diameter in a collapsed state for introduction into a body lumen to a second diameter in an expanded state for implantation within the annulus of a heart, the first annular prosthesis having a first engagement element and a first alignment element, the first alignment member being a groove; anda second annular prosthesis including a prosthetic valve, the second annular prosthesis having a second engagement element and a second alignment element, the second alignment member being a rib that is configured to slide within the groove,wherein the first engagement element and the second engagement element are configured to engage each other to attach the first and second annular prostheses together in vivo, andwherein the groove of the first alignment element slides within the rib of the second alignment element, when the first annular prosthesis and the second annular prosthesis are brought into engagement with each other in vivo, to longitudinally align the second annular prosthesis with the first annular prosthesis as the second annular prosthesis is inserted into engagement with the first annular prosthesis.
  • 14. The prosthetic valve assembly of claim 13, wherein when the second annular prosthesis is positioned within the first annular prosthesis the first and second alignment elements engage each other to prevent rotation of the first annular prosthesis relative to the second annular prosthesis.
  • 15. The prosthetic valve assembly of claim 13, wherein the first and second engagement elements provide a snap-fit connection between the first and second annular prostheses.
  • 16. The prosthetic valve assembly of claim 13, wherein the first and second engagement elements provide a magnetic connection between the first and second annular prostheses.
  • 17. The prosthetic valve assembly of claim 13, wherein the frame of the first annular prosthesis is resiliently circumferentially expandable.
  • 18. The prosthetic valve assembly of claim 13, wherein the frame of the first annular prosthesis is mechanically circumferentially expandable.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No. 15/096,788, filed Apr. 12, 2016, now abandoned, which is a continuation of U.S. application Ser. No. 14/087,354, filed Nov. 22, 2013, now U.S. Pat. No. 9,333,078, which is a continuation of U.S. application Ser. No. 13/240,426, filed Sep. 22, 2011, now U.S. Pat. No. 8,623,080, which is a continuation of U.S. application Ser. No. 10/355,429, filed Jan. 31, 2003, now U.S. Pat. No. 8,025,695, which is a continuation of U.S. application Ser. No. 10/327,821, filed Dec. 20, 2002, now U.S. Pat. No. 8,551,162, and the disclosure of these applications are incorporated in their entireties by reference herein.

US Referenced Citations (617)
Number Name Date Kind
3143742 Crowe Aug 1964 A
3320974 High et al. May 1967 A
3370305 Goott et al. Feb 1968 A
3371352 Siposs Mar 1968 A
3409013 Berry Nov 1968 A
3464065 Cromie Sep 1969 A
3546710 Shumakov et al. Dec 1970 A
3571815 Somyk Mar 1971 A
3628535 Ostrowsky et al. Dec 1971 A
3686740 Shiley Aug 1972 A
3691567 Cromie Sep 1972 A
3710744 Goodenough et al. Jan 1973 A
3744060 Bellhouse et al. Jul 1973 A
3755823 Hancock Sep 1973 A
3800403 Anderson Apr 1974 A
3839741 Haller Oct 1974 A
3959827 Kaster Jun 1976 A
3974854 Kurpanek Aug 1976 A
3996623 Kaster Dec 1976 A
3997923 Possis Dec 1976 A
4035849 Angell et al. Jul 1977 A
4078268 Possis Mar 1978 A
4078468 Civitello Mar 1978 A
4084268 Ionexcu et al. Apr 1978 A
4106129 Carpentier et al. Aug 1978 A
4164046 Cooley Aug 1979 A
4172295 Batten Oct 1979 A
4211325 Wright Jul 1980 A
4217665 Bex et al. Aug 1980 A
4218782 Rygg Aug 1980 A
4245358 Moasser Jan 1981 A
4259753 Liotta et al. Apr 1981 A
4291420 Reul Sep 1981 A
4297749 Davis et al. Nov 1981 A
RE30912 Hancock Apr 1982 E
4343048 Ross et al. Aug 1982 A
4364126 Rosen et al. Dec 1982 A
4388735 Ionescu et al. Jun 1983 A
4441216 Ionescu et al. Apr 1984 A
4451936 Carpentier et al. Jun 1984 A
4470157 Love Sep 1984 A
4477930 Totten et al. Oct 1984 A
4485816 Krumme Dec 1984 A
4501030 Lane Feb 1985 A
4506394 Bedard Mar 1985 A
4535483 Klawitter et al. Aug 1985 A
4548202 Duncan Nov 1985 A
4605407 Black et al. Aug 1986 A
4626255 Reichart et al. Dec 1986 A
4629459 Ionescu et al. Dec 1986 A
4665906 Jervis May 1987 A
4666442 Arru et al. May 1987 A
4680031 Alonso Jul 1987 A
4683883 Martin Aug 1987 A
4687483 Fisher et al. Aug 1987 A
4692164 Dzemeshkievich et al. Sep 1987 A
4702250 Ovil et al. Oct 1987 A
4705516 Barone et al. Nov 1987 A
4725274 Lane et al. Feb 1988 A
4731074 Rousseau et al. Mar 1988 A
4743253 Magladry May 1988 A
4758151 Arru et al. Jul 1988 A
4775378 Knoch et al. Oct 1988 A
4778461 Pietsch et al. Oct 1988 A
4790843 Carpentier et al. Dec 1988 A
4816029 Penny et al. Apr 1989 A
4851000 Gupta Jul 1989 A
4860031 Lejcek Aug 1989 A
4865600 Carpentier et al. Sep 1989 A
4888009 Lederman et al. Dec 1989 A
4892541 Alonso Jan 1990 A
4914097 Oda et al. Apr 1990 A
4917698 Carpentier et al. Apr 1990 A
4935030 Alonso Jun 1990 A
4960424 Grooters Oct 1990 A
4993428 Arms Feb 1991 A
4994077 Dobben Feb 1991 A
5002567 Bona et al. Mar 1991 A
5010892 Colvin et al. Apr 1991 A
5032128 Alonso Jul 1991 A
5035708 Wieting et al. Jul 1991 A
5037434 Lane Aug 1991 A
5071431 Sauter et al. Dec 1991 A
5104406 Curcio et al. Apr 1992 A
5147391 Lane Sep 1992 A
5163953 Vince Nov 1992 A
5163954 Curcio et al. Nov 1992 A
5163955 Love et al. Nov 1992 A
5178633 Peters Jan 1993 A
5192303 Gattuma Mar 1993 A
5258023 Reger Nov 1993 A
5316016 Adams et al. May 1994 A
5326370 Love et al. Jul 1994 A
5326371 Love et al. Jul 1994 A
5332402 Teitelbaum Jul 1994 A
5370685 Stevens Dec 1994 A
5376112 Duran Dec 1994 A
5396887 Imran Mar 1995 A
5397346 Walker et al. Mar 1995 A
5397348 Campbell et al. Mar 1995 A
5397351 Pavcnik et al. Mar 1995 A
5406857 Eberhardt et al. Apr 1995 A
5411552 Andersen et al. May 1995 A
5423887 Love et al. Jun 1995 A
5425741 Lemp et al. Jun 1995 A
5431676 Dubrul et al. Jun 1995 A
5449384 Johnson Sep 1995 A
5449385 Religa et al. Sep 1995 A
5469868 Reger Nov 1995 A
5476510 Eberhardt et al. Dec 1995 A
5488789 Religa et al. Feb 1996 A
5489298 Love et al. Feb 1996 A
5500016 Fisher Mar 1996 A
5533515 Coller et al. Jun 1996 A
5531784 Love et al. Jul 1996 A
5549665 Vesely et al. Aug 1996 A
5549666 Hata et al. Aug 1996 A
5562729 Purdy et al. Oct 1996 A
5571215 Sterman et al. Nov 1996 A
5573007 Bobo, Sr. Nov 1996 A
5573543 Akopov Nov 1996 A
5578076 Krueger et al. Nov 1996 A
5584803 Stevens et al. Dec 1996 A
5607470 Milo Mar 1997 A
5613982 Goldstein Mar 1997 A
5618307 Donlon et al. Apr 1997 A
5626607 Malecki et al. May 1997 A
5628789 Vanney et al. May 1997 A
5662704 Gross Sep 1997 A
5669917 Sauer Sep 1997 A
5693090 Unsworth et al. Dec 1997 A
5695503 Kruegger et al. Dec 1997 A
5720755 Dakov Jan 1998 A
5713952 Vanney et al. Feb 1998 A
5713953 Vallana et al. Feb 1998 A
5716370 Williamson Feb 1998 A
5716399 Love Feb 1998 A
5725554 Simon Mar 1998 A
5728064 Burns et al. Mar 1998 A
5728151 Garrison et al. Mar 1998 A
5735394 Krueger et al. Apr 1998 A
5752522 Murphy May 1998 A
5755782 Love et al. May 1998 A
5766240 Johnson Jun 1998 A
5776187 Krueger et al. Jul 1998 A
5776188 Shepherd et al. Jul 1998 A
5800527 Jansen et al. Sep 1998 A
5800531 Cosgrove et al. Sep 1998 A
5807405 Vanney et al. Sep 1998 A
5814097 Sterman et al. Sep 1998 A
5814098 Hinnenkamp et al. Sep 1998 A
5814100 Carpentier et al. Sep 1998 A
5824060 Christie et al. Oct 1998 A
5824061 Quijano et al. Oct 1998 A
5824064 Taheri Oct 1998 A
5830239 Toomes Nov 1998 A
5840081 Andersen et al. Nov 1998 A
5843179 Vanney et al. Dec 1998 A
5848969 Panescu et al. Dec 1998 A
5855563 Kaplan et al. Jan 1999 A
5855601 Bessler et al. Jan 1999 A
5855603 Reif Jan 1999 A
5860992 Daniel Jan 1999 A
5861028 Angell Jan 1999 A
5865801 Houser Feb 1999 A
5873906 Lau et al. Feb 1999 A
5876436 Vanney et al. Mar 1999 A
5879371 Gardiner et al. Mar 1999 A
5891160 Williamson, IV et al. Apr 1999 A
5891195 Klostermeyer et al. Apr 1999 A
5895420 Mirsch, II et al. Apr 1999 A
5902308 Murphy May 1999 A
5908450 Gross et al. Jun 1999 A
5908452 Bokros et al. Jun 1999 A
5910170 Reiminik et al. Jun 1999 A
5919147 Jain Jul 1999 A
5921934 Teo Jul 1999 A
5921935 Hickey Jul 1999 A
5924984 Rao Jul 1999 A
5925061 Ogi et al. Jul 1999 A
5925063 Khosravi Jul 1999 A
5931969 Carpentier et al. Aug 1999 A
5935163 Gabbay Aug 1999 A
5957940 Tanner et al. Sep 1999 A
5957949 Leonhardt et al. Sep 1999 A
5961549 Nguyen et al. Oct 1999 A
5961550 Carpentier Oct 1999 A
5972004 Williamson, IV et al. Oct 1999 A
5972024 Northrup, III Oct 1999 A
5976183 Ritz Nov 1999 A
5984959 Robertson et al. Nov 1999 A
5984973 Girard et al. Nov 1999 A
6007577 Vanney et al. Dec 1999 A
6010531 Donlon et al. Jan 2000 A
6042607 Williamson et al. Mar 2000 A
6045576 Starr et al. Apr 2000 A
6066160 Colvin et al. May 2000 A
6068657 Lapeyre et al. May 2000 A
6074041 Gardiner et al. Jun 2000 A
6074417 Peredo Jun 2000 A
6074418 Buchanan et al. Jun 2000 A
6081737 Shah Jun 2000 A
6083179 Oredsson Jul 2000 A
6096074 Pedros Aug 2000 A
6099475 Seward et al. Aug 2000 A
6102944 Huynh et al. Aug 2000 A
6106550 Magovem et al. Aug 2000 A
6110200 Hinnenkamp Aug 2000 A
6113632 Reif Sep 2000 A
6117091 Young et al. Sep 2000 A
6126007 Kari et al. Oct 2000 A
6129758 Love Oct 2000 A
6139575 Shu et al. Oct 2000 A
6143024 Campbell et al. Nov 2000 A
6143025 Stobie et al. Nov 2000 A
6149658 Gardiner et al. Nov 2000 A
6152935 Kammerer et al. Nov 2000 A
6162233 Williamson, IV et al. Dec 2000 A
6165183 Kuehn et al. Dec 2000 A
6168614 Andersen et al. Jan 2001 B1
6176877 Buchanan et al. Jan 2001 B1
6183512 Howanec, Jr. et al. Feb 2001 B1
6197054 Hamblin, Jr. et al. Mar 2001 B1
6200306 Klostermeyer Mar 2001 B1
6203553 Robertson Mar 2001 B1
6214043 Kruegger et al. Apr 2001 B1
6217610 Carpentier et al. Apr 2001 B1
6217611 Klostermeyer Apr 2001 B1
6231561 Frazier et al. May 2001 B1
6231602 Carpentier et al. May 2001 B1
6241765 Griffin et al. Jun 2001 B1
6245102 Jayaraman Jun 2001 B1
6245105 Nguyen et al. Jun 2001 B1
6254636 Peredo Jul 2001 B1
6264691 Gabbay Jul 2001 B1
6270526 Cox Aug 2001 B1
6270527 Campbell et al. Aug 2001 B1
6283127 Sterman et al. Sep 2001 B1
6283995 Moe et al. Sep 2001 B1
6287339 Vazquez et al. Sep 2001 B1
6290674 Roue et al. Sep 2001 B1
6299638 Sauter Oct 2001 B1
6309417 Spence et al. Oct 2001 B1
6312447 Grimes Nov 2001 B1
6312465 Griffin et al. Nov 2001 B1
6319280 Schoon Nov 2001 B1
6319281 Patel Nov 2001 B1
6322588 Ogle et al. Nov 2001 B1
6328727 Frazier et al. Dec 2001 B1
6328763 Love et al. Dec 2001 B1
6334446 Beyar Jan 2002 B1
6338740 Carpentier Jan 2002 B1
6350281 Rhee Feb 2002 B1
6358278 Brendzel et al. Mar 2002 B1
6358556 Ding et al. Mar 2002 B1
6371983 Lane Apr 2002 B1
6391053 Brendzel et al. May 2002 B1
6395025 Fordenbacher et al. May 2002 B1
6402780 Williamson, IV et al. Jun 2002 B2
6409759 Peredo Jun 2002 B1
6425916 Garrison et al. Jun 2002 B1
6413275 Nguyen et al. Jul 2002 B1
6419696 Ortiz et al. Jul 2002 B1
6440164 DiMatteo et al. Aug 2002 B1
6447524 Knodel Sep 2002 B1
6458153 Bailey et al. Oct 2002 B1
6461382 Cao Oct 2002 B1
6468305 Otte Oct 2002 B1
6454799 Scherck Nov 2002 B1
6503272 Duerig et al. Jan 2003 B2
6514265 Ho et al. Feb 2003 B2
6530952 Vesely Mar 2003 B2
6547827 Carpentier et al. Apr 2003 B2
6551332 Nguyen et al. Apr 2003 B1
6558418 Carpentier et al. May 2003 B2
6569196 Vesely May 2003 B1
6582462 Andersen et al. Jun 2003 B1
6585766 Huynh et al. Jul 2003 B1
6589279 Anderson et al. Jul 2003 B1
6598307 Love et al. Jul 2003 B2
6602289 Colvin et al. Aug 2003 B1
6607541 Gardiner et al. Aug 2003 B1
6613059 Ho et al. Sep 2003 B2
6613085 Anderson et al. Sep 2003 B1
6641593 Schaller et al. Nov 2003 B1
6652578 Bailey et al. Nov 2003 B2
6660032 Klumb et al. Dec 2003 B2
6676671 Robertson et al. Jan 2004 B2
6678862 Love et al. Jan 2004 B1
6682559 Myers et al. Jan 2004 B2
6685739 DiMatteo et al. Feb 2004 B2
6692513 Streeter et al. Feb 2004 B2
6695859 Golden et al. Feb 2004 B1
6709457 Otte et al. Feb 2004 B1
6716243 Colvin et al. Apr 2004 B1
6716244 Klaco Apr 2004 B2
6716789 Cox Apr 2004 B1
6719790 Brendzel et al. Apr 2004 B2
6730118 Spenser et al. May 2004 B2
6733525 Yang et al. May 2004 B2
6764508 Roehe et al. Jul 2004 B1
6767362 Schreck Jul 2004 B2
6769434 Liddicoat et al. Aug 2004 B2
6776785 Yencho Aug 2004 B1
6786924 Ryan et al. Sep 2004 B2
6786925 Schoon et al. Sep 2004 B1
6790230 Beyersdorf et al. Sep 2004 B2
6805711 Quijano et al. Oct 2004 B2
6821297 Snyders Nov 2004 B2
6830585 Artof et al. Dec 2004 B1
6833924 Love et al. Dec 2004 B2
6846324 Stobie Jan 2005 B2
6846325 Liddicoat Jan 2005 B2
6873902 Nguyen et al. Jan 2005 B2
6872226 Cali et al. Mar 2005 B2
6893459 Macoviak May 2005 B1
6893460 Spenser et al. May 2005 B2
6896690 Lambrecht et al. May 2005 B1
6908481 Cribier Jun 2005 B2
6911043 Myers et al. Jun 2005 B2
6913607 Ainsworth et al. Jul 2005 B2
6918917 Nguyen et al. Jul 2005 B1
6921407 Nguyen et al. Jul 2005 B2
6926730 Nguyen et al. Aug 2005 B1
6929653 Streeter Aug 2005 B2
6939365 Fogarty Sep 2005 B1
6945980 Nguyen et al. Sep 2005 B2
6945997 Huynh et al. Sep 2005 B2
6960221 Ho et al. Nov 2005 B2
7011681 Vesely Mar 2006 B2
7025780 Gabbay Apr 2006 B2
7037333 Myers et al. May 2006 B2
7070616 Majercak et al. Jul 2006 B2
7083648 Yu Aug 2006 B2
7097659 Woolfson et al. Aug 2006 B2
7101396 Artof et al. Sep 2006 B2
7134184 Schreck Nov 2006 B2
7141064 Scott et al. Nov 2006 B2
7147663 Berg et al. Dec 2006 B1
7153324 Case et al. Dec 2006 B2
7172625 Shu et al. Jan 2007 B2
7175659 Hill et al. Feb 2007 B2
7182769 Ainsworth et al. Feb 2007 B2
7186265 Sharkawy et al. Mar 2007 B2
7195641 Palmaz et al. Mar 2007 B2
7201761 Wooflson et al. Apr 2007 B2
7201771 Lane Apr 2007 B2
7201772 Schwammenthal et al. Apr 2007 B2
7214344 Carpentier et al. May 2007 B2
7238200 Lee et al. Jul 2007 B2
7252682 Seguin Aug 2007 B2
7261732 Justino Aug 2007 B2
7300463 Liddicoat Nov 2007 B2
RE40377 Williamson, IV et al. Jun 2008 E
7393360 Spenser et al. Jul 2008 B2
7422603 Lane Sep 2008 B2
7445632 McGuckin, Jr. et al. Nov 2008 B2
7513909 Lane et al. Apr 2009 B2
7547313 Gardiner et al. May 2009 B2
7556647 Drews et al. Jul 2009 B2
7578843 Shu Aug 2009 B2
7708775 Rowe et al. May 2010 B2
7717955 Lane et al. May 2010 B2
7722043 Ho et al. May 2010 B2
7744611 Nguyen et al. Jun 2010 B2
7763040 Schaller et al. Jul 2010 B2
7771469 Liddicoat et al. Aug 2010 B2
7803184 McGuckin et al. Sep 2010 B2
8025695 Fogarty et al. Sep 2011 B2
8906083 Obermiller Dec 2014 B2
20010018592 Schaller et al. Apr 2001 A1
20010007956 Letac et al. Jul 2001 A1
20010021872 Bailey et al. Sep 2001 A1
20010039435 Roue et al. Nov 2001 A1
20010039436 Frazier et al. Nov 2001 A1
20010041914 Frazier et al. Nov 2001 A1
20010041915 Roue et al. Nov 2001 A1
20010044656 Williamson et al. Nov 2001 A1
20010049492 Frazier et al. Dec 2001 A1
20020026238 Lane et al. Feb 2002 A1
20020032480 Spence et al. Mar 2002 A1
20020032481 Gabbay Mar 2002 A1
20020055774 Liddicoat May 2002 A1
20020058994 Hill et al. May 2002 A1
20020058995 Stevens May 2002 A1
20020077555 Schwartz Jun 2002 A1
20020077698 Peredo Jun 2002 A1
20020091441 Nguyen et al. Jul 2002 A1
20020116054 Lundell et al. Aug 2002 A1
20020128684 Foerster Sep 2002 A1
20020151970 Garrison et al. Oct 2002 A1
20020173842 Buchanan Nov 2002 A1
20020177223 Ogle et al. Nov 2002 A1
20020183834 Klaco Dec 2002 A1
20020188348 DiMatteo et al. Dec 2002 A1
20020198594 Schreck Dec 2002 A1
20030014104 Cribier Jan 2003 A1
20030023300 Bailey et al. Jan 2003 A1
20030023302 Moe et al. Jan 2003 A1
20030023303 Palmaz et al. Jan 2003 A1
20030036791 Bonhoeffer et al. Feb 2003 A1
20030036795 Andersen et al. Feb 2003 A1
20030040792 Gabbay Feb 2003 A1
20030045902 Weadeock Mar 2003 A1
20030050693 Quijano et al. Mar 2003 A1
20030055495 Pease et al. Mar 2003 A1
20030109922 Peterson Jun 2003 A1
20030109924 Cribier Jun 2003 A1
20030114913 Spenser et al. Jun 2003 A1
20030125793 Vesely Jul 2003 A1
20030130729 Paniagua et al. Jul 2003 A1
20030136417 Fonseca et al. Jul 2003 A1
20030149477 Gabbay Aug 2003 A1
20030149478 Figulla et al. Aug 2003 A1
20030153974 Spenser et al. Aug 2003 A1
20030167089 Lane Sep 2003 A1
20030191481 Nguyen et al. Oct 2003 A1
20030199963 Tower et al. Oct 2003 A1
20030199971 Tower et al. Oct 2003 A1
20030199974 Lee et al. Oct 2003 A1
20030229394 Ogle et al. Dec 2003 A1
20030236568 Hojeibane et al. Dec 2003 A1
20040015232 Shu Jan 2004 A1
20040019374 Hojeibane et al. Jan 2004 A1
20040024452 Kruse et al. Feb 2004 A1
20040030381 Shu Feb 2004 A1
20040034411 Quijano et al. Feb 2004 A1
20040039436 Spenser et al. Feb 2004 A1
20040044406 Woolfson Mar 2004 A1
20040050393 Golden et al. Mar 2004 A1
20040068276 Golden et al. Apr 2004 A1
20040078074 Anderson et al. Apr 2004 A1
20040093075 Kuehne May 2004 A1
20040102797 Golden et al. May 2004 A1
20040106976 Bailey et al. Jun 2004 A1
20040106990 Spence et al. Jun 2004 A1
20040122514 Fogarty et al. Jun 2004 A1
20040122516 Fogarty et al. Jun 2004 A1
20040122526 Imran Jun 2004 A1
20040167573 Williamson, IV et al. Aug 2004 A1
20040167620 Ortiz et al. Aug 2004 A1
20040176839 Huynh et al. Sep 2004 A1
20040186563 Lobbi Sep 2004 A1
20040186565 Schreck Sep 2004 A1
20040193261 Berreklouw Sep 2004 A1
20040199176 Berreklouw Oct 2004 A1
20040206363 McCarthy et al. Oct 2004 A1
20040210304 Seguin et al. Oct 2004 A1
20040210305 Shu Oct 2004 A1
20040210307 Khairkhahan Oct 2004 A1
20040225355 Stevens Nov 2004 A1
20040225356 Frater Nov 2004 A1
20040236411 Sarac et al. Nov 2004 A1
20040260389 Case et al. Dec 2004 A1
20040260390 Sarac et al. Dec 2004 A1
20050010285 Lambrecht et al. Jan 2005 A1
20050027348 Case et al. Feb 2005 A1
20050033398 Seguin Feb 2005 A1
20050043760 Fogarty Feb 2005 A1
20050043790 Seguin Feb 2005 A1
20050060029 Le et al. Mar 2005 A1
20050065594 DiMatteo et al. Mar 2005 A1
20050065601 Lee et al. Mar 2005 A1
20050065614 Stinson Mar 2005 A1
20050070924 Schaller et al. Mar 2005 A1
20050075584 Cali Apr 2005 A1
20050075659 Realyvasquez et al. Apr 2005 A1
20050075667 Ho et al. Apr 2005 A1
20050075713 Biancucci et al. Apr 2005 A1
20050075717 Nguyen et al. Apr 2005 A1
20050075718 Nguyen et al. Apr 2005 A1
20050075719 Bergheim Apr 2005 A1
20050075720 Nguyen et al. Apr 2005 A1
20050075724 Svanidze et al. Apr 2005 A1
20050080454 Drews Apr 2005 A1
20050096738 Cali et al. May 2005 A1
20050098547 Cali et al. May 2005 A1
20050101975 Nguyen et al. May 2005 A1
20050107871 Realyvasquez et al. May 2005 A1
20050131429 Ho et al. Jun 2005 A1
20050137682 Justino Jun 2005 A1
20050137686 Salahieh et al. Jun 2005 A1
20050137687 Salahieh et al. Jun 2005 A1
20050137688 Salahieh et al. Jun 2005 A1
20050137689 Salahieh et al. Jun 2005 A1
20050137690 Salahieh et al. Jun 2005 A1
20050137691 Salahieh et al. Jun 2005 A1
20050137692 Haug et al. Jun 2005 A1
20050137694 Haug et al. Jun 2005 A1
20050137695 Salahieh et al. Jun 2005 A1
20050137696 Salahieh et al. Jun 2005 A1
20050137702 Haug et al. Jun 2005 A1
20050150775 Zhang et al. Jul 2005 A1
20050159811 Lane Jul 2005 A1
20050165477 Anduiza et al. Jul 2005 A1
20050165479 Lane Jul 2005 A1
20050182483 Osborne et al. Aug 2005 A1
20050182486 Gabbay Aug 2005 A1
20050192665 Spenser et al. Sep 2005 A1
20050203616 Cribier Sep 2005 A1
20050203617 Forster et al. Sep 2005 A1
20050203618 Sharkaway et al. Sep 2005 A1
20050216079 Macoviak Sep 2005 A1
20050222674 Paine Oct 2005 A1
20050234545 Nugent et al. Oct 2005 A1
20050234546 Nuget et al. Oct 2005 A1
20050240259 Sisken et al. Oct 2005 A1
20050240263 Fogarty Oct 2005 A1
20050251252 Stobie Nov 2005 A1
20050261765 Liddicoat Nov 2005 A1
20050283231 Haug et al. Dec 2005 A1
20050384334 Haug et al. Dec 2005
20060004389 Nguyen et al. Jan 2006 A1
20060005129 Damm et al. Jan 2006 A1
20060025857 Bergheim et al. Feb 2006 A1
20060052867 Revuelta et al. Mar 2006 A1
20060058871 Zakay et al. Mar 2006 A1
20060058872 Salahieh et al. Mar 2006 A1
20060074484 Huber Apr 2006 A1
20060085060 Campbell Apr 2006 A1
20060095125 Chinn et al. May 2006 A1
20060122634 Ino Jun 2006 A1
20060122692 Gilad et al. Jun 2006 A1
20060135964 Vesely Jun 2006 A1
20060136052 Vesely Jun 2006 A1
20060136054 Berg et al. Jun 2006 A1
20060149360 Schwammenthal et al. Jul 2006 A1
20060149367 Sieracki Jul 2006 A1
20060154230 Cunanan Jul 2006 A1
20060161249 Realyvasquez et al. Jul 2006 A1
20060167543 Bailey et al. Jul 2006 A1
20060173537 Yang et al. Aug 2006 A1
20060195183 Navia et al. Aug 2006 A1
20060195184 Lane Aug 2006 A1
20060195185 Lane Aug 2006 A1
20060195186 Drews Aug 2006 A1
20060207031 Cunanan et al. Sep 2006 A1
20060229708 Powell et al. Oct 2006 A1
20060235508 Lane Oct 2006 A1
20060241745 Solem Oct 2006 A1
20060246888 Bender et al. Nov 2006 A1
20060253191 Salahieh et al. Nov 2006 A1
20060259134 Schwammenthal et al. Nov 2006 A1
20060259135 Navia et al. Nov 2006 A1
20060259136 Nguyen et al. Nov 2006 A1
20060265056 Nguyen et al. Nov 2006 A1
20060271172 Tehrani Nov 2006 A1
20060271175 Woofson et al. Nov 2006 A1
20060276888 Lee Dec 2006 A1
20060287717 Rowe et al. Dec 2006 A1
20060287719 Rowe et al. Dec 2006 A1
20070010835 Breton et al. Jan 2007 A1
20070010876 Salahieh et al. Jan 2007 A1
20070010877 Salahieh et al. Jan 2007 A1
20070016285 Lane Jan 2007 A1
20070016286 Herrmann et al. Jan 2007 A1
20070016288 Gurskis Jan 2007 A1
20070027461 Gardiner et al. Feb 2007 A1
20070035361 Rijssemus Feb 2007 A1
20070043435 Seguin et al. Feb 2007 A1
20070078509 Lotfy Apr 2007 A1
20070078510 Ryan Apr 2007 A1
20070095698 Cambron May 2007 A1
20070100440 Figulla et al. May 2007 A1
20070106313 Golden et al. May 2007 A1
20070129794 Realyvasquez Jun 2007 A1
20070129795 Hill et al. Jun 2007 A1
20070142848 Ainsworth et al. Jun 2007 A1
20070142906 Figulla et al. Jun 2007 A1
20070142907 Moaddeb et al. Jun 2007 A1
20070150053 Gurskis Jun 2007 A1
20070156233 Kapadia et al. Jul 2007 A1
20070162103 Case et al. Jul 2007 A1
20070162107 Haug et al. Jul 2007 A1
20070162111 Fukamachi et al. Jul 2007 A1
20070162113 Sharkawy et al. Jul 2007 A1
20070179604 Lane Aug 2007 A1
20070185565 Schwammenthal et al. Aug 2007 A1
20070198097 Zegdi Aug 2007 A1
20070203575 Forster et al. Aug 2007 A1
20070203576 Lee et al. Aug 2007 A1
20070213813 Von Segesser et al. Sep 2007 A1
20070225801 Drews et al. Sep 2007 A1
20070233237 Krivoruchko Oct 2007 A1
20070239266 Birdsall Oct 2007 A1
20070239269 Dolan et al. Oct 2007 A1
20070239273 Allen Oct 2007 A1
20070255398 Yang et al. Nov 2007 A1
20070260305 Drews et al. Nov 2007 A1
20070265701 Gurskis et al. Nov 2007 A1
20070270944 Bergheim et al. Nov 2007 A1
20070288089 Gurskis et al. Dec 2007 A1
20080004696 Vesely Jan 2008 A1
20080033543 Gurskis et al. Feb 2008 A1
20080071361 Tuval et al. Mar 2008 A1
20080071369 Tuval et al. Mar 2008 A1
20080097595 Gabbay Apr 2008 A1
20080119875 Ino et al. May 2008 A1
20080281411 Berreklouw Nov 2008 A1
20080319543 Lane Dec 2008 A1
20090036903 Ino et al. Feb 2009 A1
20090112233 Xiao Apr 2009 A1
20090192599 Lane et al. Jul 2009 A1
20090192602 Kuehn Jul 2009 A1
20090192603 Ryan Jul 2009 A1
20090192604 Gloss Jul 2009 A1
20090192605 Gloss et al. Jul 2009 A1
20090192606 Gloss et al. Jul 2009 A1
20090210052 Powell et al. Aug 2009 A1
20090264903 Lee et al. Oct 2009 A1
20090319038 Gmskis et al. Dec 2009 A1
20100030244 Woolfson et al. Feb 2010 A1
20100044410 Argentine et al. Feb 2010 A1
20100100174 Gmskis Apr 2010 A1
20100249894 Oba et al. Sep 2010 A1
20120053688 Fogarty et al. Mar 2012 A1
20150320552 Letac Nov 2015 A1
Foreign Referenced Citations (51)
Number Date Country
2356656 Jan 2000 CN
19532973 Nov 1996 DE
0084395 Aug 1986 EP
0096721 Dec 1987 EP
0125393 Dec 1987 EP
0179562 Jul 1989 EP
0826340 Mar 1998 EP
0850607 Jul 1998 EP
1057460 Dec 2000 EP
1088529 Apr 2001 EP
1171059 Jan 2002 EP
0971650 Jan 2005 EP
1171059 Nov 2005 EP
1093599 Dec 1967 GB
1477643 Jun 1977 GB
2011259 Jul 1979 GB
2056023 Mar 1981 GB
2069843 Sep 1981 GB
2254254 Oct 1992 GB
2279134 Dec 1994 GB
1116573 Jul 1985 SU
WO-8705489 Sep 1987 WO
8900084 Feb 1989 WO
9115167 Oct 1991 WO
92012690 Aug 1992 WO
92013502 Aug 1992 WO
92019184 Nov 1992 WO
9219185 Nov 1992 WO
9517139 Jun 1995 WO
9528899 Nov 1995 WO
96040006 Dec 1996 WO
9709933 Mar 1997 WO
9709944 Mar 1997 WO
9727799 Aug 1997 WO
9741801 Nov 1997 WO
9742871 Nov 1997 WO
9806329 Feb 1998 WO
9911201 Mar 1999 WO
9951169 Oct 1999 WO
0032105 Jun 2000 WO
0040176 Jul 2000 WO
0044311 Aug 2000 WO
0047139 Aug 2000 WO
WO-0047139 Aug 2000 WO
0060995 Oct 2000 WO
0064380 Nov 2000 WO
0110310 Feb 2001 WO
0110312 Feb 2001 WO
0176510 Oct 2001 WO
WO-0176510 Oct 2001 WO
03034950 May 2003 WO
Related Publications (1)
Number Date Country
20190336277 A1 Nov 2019 US
Continuations (5)
Number Date Country
Parent 15096788 Apr 2016 US
Child 16425985 US
Parent 14087354 Nov 2013 US
Child 15096788 US
Parent 13240426 Sep 2011 US
Child 14087354 US
Parent 10355429 Jan 2003 US
Child 13240426 US
Parent 10327821 Dec 2002 US
Child 10355429 US